期刊文献+

血清蛋白聚糖-1与糖尿病慢性肾脏疾病的相关性研究

The relationship between serum protein proteoglycans 1 and diabetic chronic kidney disease
下载PDF
导出
摘要 目的分析血清蛋白聚糖-1与糖尿病慢性肾脏病变的相关性。方法选取2012年12月—2014年12月收治的无微量白蛋白尿2型糖尿病(NMALB组)和微量白蛋白尿2型糖尿病(MALB组)患者,各100例,另选取50例正常人作为健康对照组,检测并比较3组患者空腹血糖(FPG)、尿素(BUN)、血肌酐(SCr)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白—胆固醇(HDL-C)、低密度脂蛋白—胆固醇(LDL-C)、极低密度脂蛋白—胆固醇(VLDL-C)、糖化血红蛋白(HbA_(1c))和血清蛋白聚糖-1。结果与健康对照组比较,NMALB组和MALB组FPG、BUN、SCr、TG、VLDL均升高,HDL-C降低(q=3.42、10.01,2.89、8.38,10.15、14.38,8.55、10.82,8.08、10.69,4.73、8.40,P均<0.01或P<0.05);MALB组FPG、BUN、SCr均高于NMALB组,HDL-C低于NMALB组(q=6.93、44.41、5.18、4.48,P均<0.01或P<0.05)。NMAL.B组和MALB组血清蛋白聚糖-1均显著高于健康对照组(t=4.27、9.25,P<0.01);MALB组血清蛋白聚糖-1显著高于NMALB组(t=10.36,P<0.01)。尿微量白蛋白和血清蛋白聚糖-1呈正相关(r^2=0.343,P<0.01)。结论糖尿病患者血清蛋白聚糖-1与尿微量白蛋白呈正相关,可作为糖尿病肾损伤的早期检测指标。 Objective To analyze the relationship between the serum protein proteoglycans 1 and diabetic chronic kidney disease.Methods From December 2012 to December 2014,selected the patients who admitted to department of endocrinology,they were divided into non-microalbuminuria in type 2 diabetes(NMALB group) and microalbuminuria in type 2diabetes(MALB group) patients,100 cases in each group,50 cases of normal healthy were selected as control group,fasting plasma glucose(FPG),blood urea nitrogen(BUN),serum creatinine(SCr),total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C),very low density lipoprotein cholesterol(VLDL-C),glycated hemoglobin(HbA_(1c)) anil serum proteoglycans 1 were detected and compared among the three groups of patients.Results Compared with the healthy control group,NMALB and MALB group's FPG,BUN,SCr,TG,VLDL-C were increased,HDL-C were decreased(q = 3.42,q =10.01,q=2.89,q =8.38,q =10.15,q =14.38,q =8.55.q = 10.82,q =8.08,q =10.69,q =4.73,q =8.40.P〈0.01 or P〈0.05);MALB group's FPG,BUN and SCr were higher in NMALB group,HDL-C were lower than NMALB group(q =6.93,q =44.41,q =5.18,5 =4.48,P〈0.01 or P〈0.05).NMALB group and MALB group's serum levels of proteoglycans 1 were significantly higher than those in healthy control group(t =4.27,t =9.25,P〈0.01);MALB group's serum level of proteoglycans 1 was significantly higher than NMALB group(t = 10.36,P〈0.01).Urine albumin and serum protein proteoglycans were positively correlated(r = 0.343,P〈0.01).Conclusion Serum proteoglycan 1 and microalbuminuria was positive correlated,it can be used as early detection indicator for diabetic kidney injury.
出处 《疑难病杂志》 CAS 2015年第12期1238-1240,共3页 Chinese Journal of Difficult and Complicated Cases
基金 湖北省科学技术研究计划重点项目(No.D20112105)
关键词 血清蛋白聚糖-1 糖尿病 肾损伤 相关性 Serum proteoglycans 1 Diabetes Kidney damage Correlation
  • 相关文献

参考文献13

  • 1Gil N,Goldberg R,Neuman T,et al.Heparanase is essential for the development of diabetic nephropathy in mice[J].Diabetes,2012,61(1):208-216.
  • 2Masola V,Gambaro G,Tibaldi E,et al.Heparanase and syndecan-l interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells[J].J Biol Chem,2012,287(2):1478-1488.
  • 3Masola V,Onisto M,Zaza G,et al.A new mechanism of action of sulodexide in diabetic nephropathy:inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition[J].J Transl Med,2012,10(1):213.
  • 4Ramani VC,Purushothaman A,Stewart MD,et al.The heparanase/syndecan-l axis in cancer:mechanisms and therapies[J].FEBS J,2013,280(10).-2294-2306.
  • 5谢燕,周宝尚,喻秀丽,童立纺.激活法尼酯X受体上调核心蛋白聚糖表达对肾小管上皮细胞转分化的作用[J].免疫学杂志,2012,28(7):600-603. 被引量:3
  • 6Yang WY,Lu JM,Weng JP,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
  • 7Kuwabara A,Satoh M,Tomita N,et al.Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats[J].Diabetologia,2010,53(9):2056-2065.
  • 8Wang JB,Zhang YJ,Guan J,et al.Enhanced syndecan-l expression on neutrophils in patients with type 2 diabetes mellitus[J].Acta Diabetol,2012,49(1):41-46.
  • 9Wang JB,Zhang YJ,Zhang Y,et al.Negative correlation between serum syndecan-l and apolipoprotein Al in patients with type 2 diabetes mellitus[J].Acta Diabetol,2013,50(2):111-115.
  • 10Goldberg R,Rubinstein AM,Gil N,et al.Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy[J].Diabetes,2014,63(12):4302-4313.

二级参考文献27

  • 1秦卫松,刘志红,曾彩虹,郑春霞,贾忠辉,王生余,黎磊石.雷公藤甲素对Heymann肾炎模型足细胞病变的影响[J].肾脏病与透析肾移植杂志,2007,16(2):101-109. 被引量:97
  • 2Chen C A, Hwang J C, Guh J Y, et al. Reduced podocyte expression of alpha3betal integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats [J]. J Lab Clin Med, 2006,147(2) : 74-82.
  • 3Raats C J, van den Born J, Bakker M A, et al. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies [J]. Am J Pathol, 2000, 156(5) : 1749-1765.
  • 4Hara M, Yanagihara T, Kihara I, et al. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury [J]. J Am Soc Nephrol, 2005,16(2) :408-416.
  • 5Kojima K, Davidovits A, Poczewski H, et al. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan-matrix interaction [J]. J Am Soc Nephrol, 2004,15(8) :2079-2089.
  • 6Regele H M, Fillipovic E, Langer B, et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclcrosis [ J ]. J Am Soc Nephrol, 2000,11 (3) : 403 -412.
  • 7Tian J, Liu Y, Williams L A, et al. Potential role of active vitamin D in retarding the progression of chronic kidney disease [J]. Nephrol Dial Transplant, 2007,22(2) : 321-328.
  • 8Kuhlmann A, Haas C S, Gross M L, et al. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat [J]. Am J Physiol Renal Physiol, 2004,286(3) : F526-F533.
  • 9Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis[J]. J Am Soc Nephrol, 2010, 21(2): 212-222.
  • 10Forman BM, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites [J]. Cell, 1995, 81(5): 687-693.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部